LONG TERM DISEASE CONTROL WITH POMALIDOMIDE AND DEXAMETHASONE IN RELAPSED/ REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL LIFE EXPERIENCE

被引：0
|
作者：
Parisi, M. [1 ]
Conticello, C. [1 ]
Leotta, S. [1 ]
Martino, E. [1 ]
Calafiore, V [1 ]
Del Fabro, V [1 ]
Pirosa, M. C. [1 ]
Romano, A. [1 ]
Di Raimondo, F. [1 ]
机构：
[1] Univ Catania, Div Hematol, AO Policlin Vittorio Emanuele, Catania, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P51
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL- LIFE EXPERIENCE
    Cerchione, C.
    Zacheo, I
    Di, Perna M.
    Nappi, D.
    Pareto, A. E.
    Peluso, I
    Ferrara, K.
    Pane, F.
    Catalano, l
    HAEMATOLOGICA, 2018, 103 : 39 - 40
  • [32] EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE FROM TURKEY
    Saydam, G.
    Soyer, N.
    Patir, P.
    Uysal, A.
    Duran, M.
    Durusoy, R.
    Sahin, F.
    Vural, F.
    Tobu, M.
    Tombuloglu, M.
    HAEMATOLOGICA, 2017, 102 : 784 - 784
  • [33] Daratumumab, Pomalidomide, and Dexamethasone (DPd) for the Treatment of Relapsed/Refractory Multiple Myeloma: A Single Institution Experience
    Abdallah, Al-Ola
    Dunavin, Neil
    McClune, Brian
    Shune, Leyla
    Dias, Ajoy L.
    Mahmoudjafari, Zahra
    Hochard, Erica
    McGuirk, Joseph P.
    Ganguly, Siddhartha
    BLOOD, 2018, 132
  • [34] BORTEZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A REAL-LIFE EXPERIENCE
    Cerchione, C.
    Zacheo, I.
    Di Perna, M.
    Nappi, D.
    Pareto, A. E.
    Peluso, I.
    Ferrara, K.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2017, 102 : 140 - 140
  • [35] Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study
    Trudel, Sabrina
    Tessoulin, Benoit
    Jullien, Maxime
    Blin, Nicolas
    Gastinne, Thomas
    Mahe, Beatrice
    Dubruille, Viviane
    Bonnet, Antoine
    Lok, Anne
    Chevallier, Patrice
    Peterlin, Pierre
    Garnier, Alice
    Guillaume, Thierry
    Le Bourgeois, Amandine
    Le Gouill, Steven
    Moreau, Philippe
    Touzeau, Cyrille
    ANNALS OF HEMATOLOGY, 2019, 98 (06) : 1441 - 1447
  • [36] Pomalidomide and Dexamethasone Are Effective in Relapsed or Refractory Multiple Myeloma in a Real-Life Setting: A Multicenter Retrospective Study in Taiwan
    Hung, Yu-Chin
    Gau, Jyh-Pyng
    Huang, Shang-Yi
    Ko, Bor-Sheng
    Teng, Chieh-Lin Jerry
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study
    Sabrina Trudel
    Benoît Tessoulin
    Maxime Jullien
    Nicolas Blin
    Thomas Gastinne
    Béatrice Mahé
    Viviane Dubruille
    Antoine Bonnet
    Anne Lok
    Patrice Chevallier
    Pierre Peterlin
    Alice Garnier
    Thierry Guillaume
    Amandine Le Bourgeois
    Steven Le Gouill
    Philippe Moreau
    Cyrille Touzeau
    Annals of Hematology, 2019, 98 : 1441 - 1447
  • [38] POMALIDOMIDE IN RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM): EXPERIENCE CENTER
    Cuesta Garcia, A.
    HAEMATOLOGICA, 2015, 100 : 104 - 104
  • [39] Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world: The retrospective IMAGE study
    Decaux, Olivier
    Fontan, Jean
    Perrot, Aurore
    Karlin, Lionel
    Touzeau, Cyrille
    Schulmann, Samantha
    Manier, Salomon
    Belhadj, Karim
    Trebouet, Adrien
    Zunic, Patricia
    Schiano De Colella, Jean-Marc
    Castel, Brice
    van de Wyngaert, Zoe
    Pica, Gian Matteo
    Tiab, Mourad
    Kuhnowski, Frederique
    Bouketouche, Malek
    Rigaudeau, Sophia
    Benramdane, Riad
    Tekle, Christina
    Lafore, Radhia
    Gaucher, Marianne
    Corre, Jill
    Leleu, Xavier
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 113 (03) : 290 - 297
  • [40] Pomalidomide and Dexamethasone Treatment for ≥ 1 Year in Renally Impaired Patients With Relapsed or Refractory Multiple Myeloma
    Weisel, Katja
    Dimopoulos, Meletios A.
    Cook, Mark
    Ramasamy, Karthik
    De La Rubia, Javier
    Ardizzoia, Antonio
    Krauth, Maria Theresa
    Jaccard, Arnaud
    Van de Donk, Niels
    Kueenburg, Elisabeth
    Di Micco, Antonia
    Rosettani, Barbara
    Atiba-Davies, Margaret
    Bacon, Pamela
    Sonneveld, Pieter
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E284 - E285
12345